NCT00530283

Brief Summary

Patients with squamous cell cancer of neck nodes but unknown primary will have a PET-CT scan prior to biopsies. The utility of PET-CT will be determined in this subset of patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2007

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 13, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 17, 2007

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

October 21, 2019

Status Verified

August 1, 2011

Enrollment Period

2.9 years

First QC Date

September 13, 2007

Last Update Submit

October 17, 2019

Conditions

Squamous Cell Cancer

Keywords

SquamousUnknown PrimaryPatients with Squamous cell cancer neck nodes

Study Arms (1)

A

Patients with Squamous cell cancer of neck nodes, unknown primary

Other: PET-CT

Interventions

PET-CTOTHER
A

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

18 years

You may qualify if:

  • squamous cell cancer of neck nodes with unknown primary site

You may not qualify if:

  • unable to tolerate PET-CT
  • unable to undergo examination under anaesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tom Baker Cancer Centre

Calgary, Alberta, T2N 4N2, Canada

Location

MeSH Terms

Conditions

Neoplasms, Squamous Cell

Condition Hierarchy (Ancestors)

Neoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Harold Lau, M.D.

    AHS Cancer Control Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2007

First Posted

September 17, 2007

Study Start

August 1, 2007

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

October 21, 2019

Record last verified: 2011-08

Locations

CA(1)